Merit Medical Systems Inc. (MMSI) Tops Q4 EPS by 19c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
February 24, 2022 4:05 PM ESTQ4 2021 reported revenue of $278.5 million, up 7.9% on a reported basis and up 8.4% on a constant currency revenue, organic* basis, compared to Q4 2020Q4 2021 GAAP EPS increased 32% year-over-year to $0.36, compared to $0.27 in Q4 2020Q4 2021 non-GAAP EPS* increased 31% year-over-year to $0.71, compared to $0.54 in Q4 2020FY21 reported revenue of $1.075 billion, up 11.5% on a reported basis and up 10.4% on a constant currency revenue, organic* basis, compared to FY20FY21 GAAP EPS was $0.84, compared to loss per share of ($0.18) in FY20FY21 non-GAAP EPS* increased 43% year-over-year to $2.37, compared to $1.65 in FY20
*Â Â Constant currency revenue;... More
